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INTRODUCTION
1n 1938 with the passage of the FD & C Act, pre-existing plantbased drugs, such as atropine, codeine, and morphine, were "grandfathered" into approved use in the United States along with everything listed in the United States PharmacopoeiaNational Formulary. Herbals were exempted from registration as drugs following a review commissioned by the FDA (authorized by the Kefauver-Harris amendments in 1962) from the National Academy of Sciences.
Herbals are now considered dietary supplements. They are being widely utilized; however, treating physicians may not be aware that patients are taking them. The Eisenberg report in JAMA (1998) stated that 42% of those surveyed used some alternative forms of medical therapy (increased from 34% in a 1991 survey). While the percentage that used herbals was relatively low at 12%, this was dramatically increased from 2.5% in the 1991 survey. Other published estimates of herbal medication use have ranged as high as 30% in certain ethnic or patient populations. In 1994, the United States Dietary Supplement Health Education Act (USDSHEA) was passed, designating the FDA Center for Food Safety and Applied Nutrition (CFSAN) with responsibility for developing regulations for dietary supplements, which include amino acids, biological extracts, herbals, minerals, and vitamins. In 1995, a National Center for Complementary and Alternative Medicine (NCCAM) was established at NIH with a growing budget for sponsored research. In May 1998, the dietary supplement branch of CFSAN published a container labeling requirement, and a 10-year plan was issued in January 2000 for the total regulation of dietary supplements.
